Ligand · Q6B
Q6B · [(6~{S},7~{S},9~{Z},12~{R})-12-[(~{Z},2~{S},6~{R}, 7~{R},9~{R})-4,6-dimethyl-7,9-bis(oxidanyl)dec-4-en-2-yl]-7,9-dimethyl-2-oxidanylidene-1-oxacyclododec-9-en-6-yl] (2~{E},4~{E},6~{E},8~{E},10~{E},12~{S},13~{S}, 15~{S})-4,6,10-trimethyl-12,13,15-tris(oxidanyl) hexadeca-2,4,6,8,10-pentaenoate
Q6B, [(6~{S},7~{S},9~{Z},12~{R})-12-[(~{Z},2~{S},6~{R}, 7~{R},9~{R})-4,6-dimethyl-7,9-bis(oxidanyl)dec-4-en-2-yl]-7,9-dimethyl-2-oxidanylidene-1-oxacyclododec-9-en-6-yl] (2~{E},4~{E},6~{E},8~{E},10~{E},12~{S},13~{S}…
- Component
- Q6B
- Formula
- C44 H70 O9
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
Q6B in 1 structure; the first of them:
- 6Z3T · Structure of canine SEC61 inhibited by mycolactone · Q6B A501 · binds VAL85, THR86, LEU89, TRP379
Residues it binds most
LEU 1, THR 1, TRP 1, VAL 1 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.